Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification ; volume:83 ; number:15 ; day:20 ; month:9 ; year:2023 ; pages:1387-1408 ; date:10.2023
Drugs ; 83, Heft 15 (20.9.2023), 1387-1408, 10.2023
- Urheber
-
Cummings, Jeffrey L.
Osse, Amanda M. Leisgang
Kinney, Jefferson W.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40265-023-01938-w
- URN
-
urn:nbn:de:101:1-2024010808542675793534
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
17.08.2024, 08:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cummings, Jeffrey L.
- Osse, Amanda M. Leisgang
- Kinney, Jefferson W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Alzheimer’s Disease Drug Development Pipeline 2020
Advances in Alzheimer’s Disease Drug Development
The Alzheimer’s disease drug development landscape
Geroscience and Alzheimer’s Disease Drug Development
Alzheimer’s Disease
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
Alzheimer's disease
APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets
Non-drug Therapies for Alzheimer’s Disease: A Review
Alzheimer’s Disease Drug Development Pipeline 2020
Advances in Alzheimer’s Disease Drug Development
The Alzheimer’s disease drug development landscape
Geroscience and Alzheimer’s Disease Drug Development
Alzheimer’s Disease
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
Alzheimer's disease
APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets
Non-drug Therapies for Alzheimer’s Disease: A Review
Alzheimer’s Disease Drug Development Pipeline 2020
Advances in Alzheimer’s Disease Drug Development
The Alzheimer’s disease drug development landscape
Geroscience and Alzheimer’s Disease Drug Development
Alzheimer’s Disease
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
Alzheimer's disease
APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets